Effects of acetate dialysate on transforming growth factor β1, interleukin, and β2-microglobulin plasma levels

John Anderson, Gary Briefel, Joe M. Jones, J. H. Ryu, Marielena Mcguire, Yeo Pyo Yun

Research output: Contribution to journalArticle

Abstract

To evaluate potential adverse effects of acetate use in hemodialysis (HD), we measured plasma interleukin (IL-1α, IL-1β, IL-6). TNFα, TGFβ1, and β2-microglobulin levels with ELISA assays in normal (N = 9), CRF (N = 6), CAPD (N = 7) and HD (N = 8) subjects and compared the effects of acetate (Ac) and acetate-free (Ac-free) dialysate. TGFβ1, was the only cytokine consistently detected. Compared to normals (median 57, range 53 to 68 pg/ml, one undetected; N = 8). TGFβ1, was higher in the CRF (75, 70 to 97 pg/ml, one undetected) and CAPD (75.5, 66 to 116 pg/ml. N = 6) groups (P <0.05), and was somewhat higher in the HD (68, 52 to 88 pg/ml) group (P <0.10). Acutely, TGFβ1, pre-HD (70, 63 to 88 pg/ml) increased above normals post AcHD [79.5. 65 to 140 pg/ml uncorrected for Ultrafiltration (UF)] and was higher after AcHD versus Ac-free HD both uncorrected (79.5. 65 to 140 pg/ml vs. 70, 52 to 86 pg/ml) and corrected for UF (68, 51 to 115 pg/ml vs. 57, 43 to 69 pg/ml; P <0.05). β2-microglobulin was not different after AcHD (81.2 ± 8.0 mg/ml) versus Ac-free HD (72.5 ± 6.9 mg/ml). Signifcantly lower serum inorganic phosphorus was also found four hours post-AcHD compared to four hours post-Ac-free HD (0.87 mmol ± 0.10 SEM vs. 1.05 mmol ± 0.07 SEM; P <0.05). Inflammatory cytokines may, therefore, not be detectable with standard ELISA assays even after HD. TGFβ1, which stimulates extracellular matrix and collagen synthesis and modulates other cytokines. could affect the progression of CRF and combined with acetate's possible effects on phosphate kinetics, could play a role in ectopic calcifications and renal bone disease. Finally, no effect of acetate on β2-microglobulin levels was found.

Original languageEnglish (US)
Pages (from-to)1110-1117
Number of pages8
JournalKidney International
Volume40
Issue number6
StatePublished - Dec 1991

Fingerprint

Dialysis Solutions
Transforming Growth Factors
Interleukin-2
Renal Dialysis
Acetates
Interleukin-1
Continuous Ambulatory Peritoneal Dialysis
Ultrafiltration
Cytokines
Enzyme-Linked Immunosorbent Assay
Bone Diseases
Phosphorus
Extracellular Matrix
Interleukin-6
Collagen
Phosphates
Kidney
Serum

ASJC Scopus subject areas

  • Nephrology

Cite this

Anderson, J., Briefel, G., Jones, J. M., Ryu, J. H., Mcguire, M., & Yun, Y. P. (1991). Effects of acetate dialysate on transforming growth factor β1, interleukin, and β2-microglobulin plasma levels. Kidney International, 40(6), 1110-1117.

Effects of acetate dialysate on transforming growth factor β1, interleukin, and β2-microglobulin plasma levels. / Anderson, John; Briefel, Gary; Jones, Joe M.; Ryu, J. H.; Mcguire, Marielena; Yun, Yeo Pyo.

In: Kidney International, Vol. 40, No. 6, 12.1991, p. 1110-1117.

Research output: Contribution to journalArticle

Anderson, J, Briefel, G, Jones, JM, Ryu, JH, Mcguire, M & Yun, YP 1991, 'Effects of acetate dialysate on transforming growth factor β1, interleukin, and β2-microglobulin plasma levels', Kidney International, vol. 40, no. 6, pp. 1110-1117.
Anderson J, Briefel G, Jones JM, Ryu JH, Mcguire M, Yun YP. Effects of acetate dialysate on transforming growth factor β1, interleukin, and β2-microglobulin plasma levels. Kidney International. 1991 Dec;40(6):1110-1117.
Anderson, John ; Briefel, Gary ; Jones, Joe M. ; Ryu, J. H. ; Mcguire, Marielena ; Yun, Yeo Pyo. / Effects of acetate dialysate on transforming growth factor β1, interleukin, and β2-microglobulin plasma levels. In: Kidney International. 1991 ; Vol. 40, No. 6. pp. 1110-1117.
@article{7daa1ba1a1af48b2bc042e2cc0ec31d9,
title = "Effects of acetate dialysate on transforming growth factor β1, interleukin, and β2-microglobulin plasma levels",
abstract = "To evaluate potential adverse effects of acetate use in hemodialysis (HD), we measured plasma interleukin (IL-1α, IL-1β, IL-6). TNFα, TGFβ1, and β2-microglobulin levels with ELISA assays in normal (N = 9), CRF (N = 6), CAPD (N = 7) and HD (N = 8) subjects and compared the effects of acetate (Ac) and acetate-free (Ac-free) dialysate. TGFβ1, was the only cytokine consistently detected. Compared to normals (median 57, range 53 to 68 pg/ml, one undetected; N = 8). TGFβ1, was higher in the CRF (75, 70 to 97 pg/ml, one undetected) and CAPD (75.5, 66 to 116 pg/ml. N = 6) groups (P <0.05), and was somewhat higher in the HD (68, 52 to 88 pg/ml) group (P <0.10). Acutely, TGFβ1, pre-HD (70, 63 to 88 pg/ml) increased above normals post AcHD [79.5. 65 to 140 pg/ml uncorrected for Ultrafiltration (UF)] and was higher after AcHD versus Ac-free HD both uncorrected (79.5. 65 to 140 pg/ml vs. 70, 52 to 86 pg/ml) and corrected for UF (68, 51 to 115 pg/ml vs. 57, 43 to 69 pg/ml; P <0.05). β2-microglobulin was not different after AcHD (81.2 ± 8.0 mg/ml) versus Ac-free HD (72.5 ± 6.9 mg/ml). Signifcantly lower serum inorganic phosphorus was also found four hours post-AcHD compared to four hours post-Ac-free HD (0.87 mmol ± 0.10 SEM vs. 1.05 mmol ± 0.07 SEM; P <0.05). Inflammatory cytokines may, therefore, not be detectable with standard ELISA assays even after HD. TGFβ1, which stimulates extracellular matrix and collagen synthesis and modulates other cytokines. could affect the progression of CRF and combined with acetate's possible effects on phosphate kinetics, could play a role in ectopic calcifications and renal bone disease. Finally, no effect of acetate on β2-microglobulin levels was found.",
author = "John Anderson and Gary Briefel and Jones, {Joe M.} and Ryu, {J. H.} and Marielena Mcguire and Yun, {Yeo Pyo}",
year = "1991",
month = "12",
language = "English (US)",
volume = "40",
pages = "1110--1117",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Effects of acetate dialysate on transforming growth factor β1, interleukin, and β2-microglobulin plasma levels

AU - Anderson, John

AU - Briefel, Gary

AU - Jones, Joe M.

AU - Ryu, J. H.

AU - Mcguire, Marielena

AU - Yun, Yeo Pyo

PY - 1991/12

Y1 - 1991/12

N2 - To evaluate potential adverse effects of acetate use in hemodialysis (HD), we measured plasma interleukin (IL-1α, IL-1β, IL-6). TNFα, TGFβ1, and β2-microglobulin levels with ELISA assays in normal (N = 9), CRF (N = 6), CAPD (N = 7) and HD (N = 8) subjects and compared the effects of acetate (Ac) and acetate-free (Ac-free) dialysate. TGFβ1, was the only cytokine consistently detected. Compared to normals (median 57, range 53 to 68 pg/ml, one undetected; N = 8). TGFβ1, was higher in the CRF (75, 70 to 97 pg/ml, one undetected) and CAPD (75.5, 66 to 116 pg/ml. N = 6) groups (P <0.05), and was somewhat higher in the HD (68, 52 to 88 pg/ml) group (P <0.10). Acutely, TGFβ1, pre-HD (70, 63 to 88 pg/ml) increased above normals post AcHD [79.5. 65 to 140 pg/ml uncorrected for Ultrafiltration (UF)] and was higher after AcHD versus Ac-free HD both uncorrected (79.5. 65 to 140 pg/ml vs. 70, 52 to 86 pg/ml) and corrected for UF (68, 51 to 115 pg/ml vs. 57, 43 to 69 pg/ml; P <0.05). β2-microglobulin was not different after AcHD (81.2 ± 8.0 mg/ml) versus Ac-free HD (72.5 ± 6.9 mg/ml). Signifcantly lower serum inorganic phosphorus was also found four hours post-AcHD compared to four hours post-Ac-free HD (0.87 mmol ± 0.10 SEM vs. 1.05 mmol ± 0.07 SEM; P <0.05). Inflammatory cytokines may, therefore, not be detectable with standard ELISA assays even after HD. TGFβ1, which stimulates extracellular matrix and collagen synthesis and modulates other cytokines. could affect the progression of CRF and combined with acetate's possible effects on phosphate kinetics, could play a role in ectopic calcifications and renal bone disease. Finally, no effect of acetate on β2-microglobulin levels was found.

AB - To evaluate potential adverse effects of acetate use in hemodialysis (HD), we measured plasma interleukin (IL-1α, IL-1β, IL-6). TNFα, TGFβ1, and β2-microglobulin levels with ELISA assays in normal (N = 9), CRF (N = 6), CAPD (N = 7) and HD (N = 8) subjects and compared the effects of acetate (Ac) and acetate-free (Ac-free) dialysate. TGFβ1, was the only cytokine consistently detected. Compared to normals (median 57, range 53 to 68 pg/ml, one undetected; N = 8). TGFβ1, was higher in the CRF (75, 70 to 97 pg/ml, one undetected) and CAPD (75.5, 66 to 116 pg/ml. N = 6) groups (P <0.05), and was somewhat higher in the HD (68, 52 to 88 pg/ml) group (P <0.10). Acutely, TGFβ1, pre-HD (70, 63 to 88 pg/ml) increased above normals post AcHD [79.5. 65 to 140 pg/ml uncorrected for Ultrafiltration (UF)] and was higher after AcHD versus Ac-free HD both uncorrected (79.5. 65 to 140 pg/ml vs. 70, 52 to 86 pg/ml) and corrected for UF (68, 51 to 115 pg/ml vs. 57, 43 to 69 pg/ml; P <0.05). β2-microglobulin was not different after AcHD (81.2 ± 8.0 mg/ml) versus Ac-free HD (72.5 ± 6.9 mg/ml). Signifcantly lower serum inorganic phosphorus was also found four hours post-AcHD compared to four hours post-Ac-free HD (0.87 mmol ± 0.10 SEM vs. 1.05 mmol ± 0.07 SEM; P <0.05). Inflammatory cytokines may, therefore, not be detectable with standard ELISA assays even after HD. TGFβ1, which stimulates extracellular matrix and collagen synthesis and modulates other cytokines. could affect the progression of CRF and combined with acetate's possible effects on phosphate kinetics, could play a role in ectopic calcifications and renal bone disease. Finally, no effect of acetate on β2-microglobulin levels was found.

UR - http://www.scopus.com/inward/record.url?scp=0025993462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025993462&partnerID=8YFLogxK

M3 - Article

C2 - 1762311

AN - SCOPUS:0025993462

VL - 40

SP - 1110

EP - 1117

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 6

ER -